arrow
F

Federico Paolieri

azienda usl toscana centro
H指数:9
被引数:281

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer

当前对于新发低体积转移性激素敏感性前列腺癌的诊断和治疗选择

2025-05-210
PRE
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
2022-08-169
OAAI
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis

新型冠状病毒肺炎疫苗在癌症患者中的安全性和耐受性: 单中心回顾性分析

2022-06-021
OAAI
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)
2021-05-1851
OAAI
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer

雄激素受体 (AR) 剪接变体7和全长AR表达与临床结果相关: 去势抵抗性前列腺癌患者的转化研究

2019-09-2032
PREAI